Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)PR NewswireNEW BRUNSWICK, N.J., May 2, 2013 /PRNewswire/ ...
[Published Equities.com - May 02 2013]